The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Merck Sharp & Dome (Inst)
KEYNOTE-629: Phase 2 study of pembrolizumab for recurrent/metastatic or locally advanced unresectable cutaneous squamous cell carcinoma (cSCC).
 
Jean Jacques Grob
Honoraria - Amgen; Bristol-Myers Squibb; Merck; Merck Sharp & Dome; Novartis; Pfizer; Pierre Fabre; Roche; Sun Pharma
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; Merck Sharp & Dome; Novartis; Pfizer; Pierre Fabre; Roche; Sun Pharma
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb
 
Rene Gonzalez
No Relationships to Disclose
 
Nicole Basset-Seguin
No Relationships to Disclose
 
Jacob Schachter
Honoraria - Bristol-Myers Squibb; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Olga Vornicova
No Relationships to Disclose
 
Jessica Ruth Bauman
Consulting or Advisory Role - Pfizer
 
Florent Grange
Consulting or Advisory Role - Merck Sharp & Dome
 
Nicolas Meyer
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; Roche/Genentech
Research Funding - Bristol-Myers Squibb (Inst); MSD Oncology (Inst)
 
Josep M. Piulats
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Clovis Oncology; Janssen Oncology; Merck Sharp & Dohme; Roche/Genentech; VCN Biosciences
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Incyte; Janssen Oncology; Merck Sharp & Dohme; Pfizer/EMD Serono
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen Oncology; Roche
 
Eric (Pingye) Zhang
Employment - Merck
 
Burak Gumuscu
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Ramona F. Swaby
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Brett Gordon Maxwell Hughes
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; MSD Oncology; Pfizer; Roche
Research Funding - Amgen (Inst)